Global Human Organs-on-Chips Market Growth (Status and Outlook) 2023-2029

Global Human Organs-on-Chips Market Growth (Status and Outlook) 2023-2029

According to our (LP Info Research) latest study, the global Human Organs-on-Chips market size was valued at US$ 86 million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Human Organs-on-Chips is forecast to a readjusted size of US$ 612 million by 2029 with a CAGR of 32.4% during review period.

The research report highlights the growth potential of the global Human Organs-on-Chips market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Human Organs-on-Chips are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Organs-on-Chips. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Organs-on-Chips market.

An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.

The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).

In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.

Global key players of Human Organs-on-Chips include Emulate, Mimetas, TissUse, Valo Health and CN Bio Innovations. The top five players hold a share over 55%. North America is the largest market, has a share about 42%, followed by Europe, and Asia-Pacific, with share 35% and 18%, separately. In terms of product type, Liver-on-a-chip is the largest segment, occupied for a share of 26%, and in terms of application, Pharmaceutical & Biotechnology Companies has a share about 70%.

Key Features:

The report on Human Organs-on-Chips market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Human Organs-on-Chips market. It may include historical data, market segmentation by Type (e.g., Brain-on-a-chip, Liver-on-a-chip), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Organs-on-Chips market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Organs-on-Chips market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Human Organs-on-Chips industry. This include advancements in Human Organs-on-Chips technology, Human Organs-on-Chips new entrants, Human Organs-on-Chips new investment, and other innovations that are shaping the future of Human Organs-on-Chips.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Organs-on-Chips market. It includes factors influencing customer ' purchasing decisions, preferences for Human Organs-on-Chips product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Organs-on-Chips market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Organs-on-Chips market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Organs-on-Chips market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Organs-on-Chips industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Organs-on-Chips market.

Market Segmentation:

Human Organs-on-Chips market is split by Type and by End User. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of value.

Segmentation by type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs

Segmentation by end user
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.